67 related articles for article (PubMed ID: 6834268)
21. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
Mertz TE; Kaplan HR
J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
[TBL] [Abstract][Full Text] [Related]
22. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
Gautam CS; Sharma PL; Pandhi P
Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
[TBL] [Abstract][Full Text] [Related]
23. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
[TBL] [Abstract][Full Text] [Related]
24. [Antiarrhythmic properties of 3-(2-hydroxy-3 isopropylamino-propoxy)-3 phenyl-2 isoindolinone-1, (RS, SR) in the dog].
Detaille JY; Caillard CG; Mondot S; Louis JC; Julou L
C R Seances Acad Sci D; 1979 Feb; 288(5):555-8. PubMed ID: 108025
[TBL] [Abstract][Full Text] [Related]
25. The prophylaxis of AV nodal re-entry tachycardia.
Tonkin AM; Shorne L
Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
[TBL] [Abstract][Full Text] [Related]
26. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
Keren G; Tepper D; Butler B; Torres V; Somberg JC
Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
[TBL] [Abstract][Full Text] [Related]
27. Reentrant circuits in the canine atrioventricular node during atrial and ventricular echoes: electrophysiological and histological correlation.
Loh P; Ho SY; Kawara T; Hauer RN; Janse MJ; Breithardt G; de Bakker JM
Circulation; 2003 Jul; 108(2):231-8. PubMed ID: 12835215
[TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
Bödeker K; Bischoff KO; Menken U; Hager W
Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of intravenous LNC-834, a new antiarrhythmic agent, and quinidine in canine models of arrhythmia.
D'Alonzo AJ; Butterfield JL; Drexler AP; Sergio SL
J Cardiovasc Pharmacol; 1990 Sep; 16(3):506-17. PubMed ID: 1700225
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic study of patients with short P-R interval and normal QRS complex.
Moro C; Cosío FG
Eur J Cardiol; 1980 Feb; 11(2):81-90. PubMed ID: 7363927
[TBL] [Abstract][Full Text] [Related]
31. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
Verrostte JM; van Hemel NM; Kingma JH
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
[TBL] [Abstract][Full Text] [Related]
32. Potent and reversible effects of ATI-2001 on atrial and atrioventricular nodal electrophysiological properties in guinea pig isolated perfused heart.
Raatikainen MJ; Morey TE; Druzgala P; Milner P; Gonzalez MD; Dennis DM
J Pharmacol Exp Ther; 2000 Nov; 295(2):779-85. PubMed ID: 11046118
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
[TBL] [Abstract][Full Text] [Related]
34. PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs.
Rougeot C; Jozefczak C; Mestre M; Le Fur G; Uzan A
J Pharm Pharmacol; 1984 May; 36(5):347-9. PubMed ID: 6145779
[TBL] [Abstract][Full Text] [Related]
35. R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent manner.
Vos MA; van Deursen RT; Gorgels AP; Leunissen JD; Wellens HJ
Cardiovasc Res; 1993 Aug; 27(8):1491-7. PubMed ID: 8221803
[TBL] [Abstract][Full Text] [Related]
36. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
Kerin NZ; Faitel K; Naini M
Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of antiarrhythmic properties of quinicine versus quinidine (author's transl)].
Pecquet-Bathellier C; Quevauviller A
Sem Hop; 1978 Oct 8-15; 54(29-32):953-7. PubMed ID: 216087
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia.
Anderson JL; Lutz JR; Allison SB
J Am Coll Cardiol; 1983 Jul; 2(1):105-14. PubMed ID: 6853905
[No Abstract] [Full Text] [Related]
40. Efficacy and plasma concentrations of SC-36602 in canine models of ventricular arrhythmia.
Garthwaite SM; Hatley FR; Frederick LG; Cook C
J Cardiovasc Pharmacol; 1989 Feb; 13(2):218-26. PubMed ID: 2468949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
